ArticlePlastic and reconstructive surgery. Global open2026
Natural History of Subclinical Lower Limb Lymphedema After Gynecologic Cancer Surgery Using Indocyanine Green Lymphography.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Subclinical lymphedema is characterized by abnormal lymphatic findings in the absence of clinical symptoms or edema. However, the natural history of subclinical lymphedema after gynecologic cancer surgery remains unclear. Methods: In this observational cohort study, the asymptomatic lower limbs of patients treated for gynecologic malignancies were evaluated using indocyanine green (ICG) lymphography between April 2021 and June 2024. Subclinical lymphedema was defined as asymptomatic limbs with abnormal ICG findings (stage ≥ 1). Patients were followed up at approximately 6-month intervals without therapeutic intervention until objective edema developed. Time-to-event outcomes were analyzed using the Kaplan-Meier method and Cox regression. Longitudinal changes in the lower extremity lymphedema index were assessed using a mixed-effects model. Results: Eighty asymptomatic lower limbs were included, of which 26 were classified as subclinical. During a median follow-up of 24 months, objective edema developed more frequently in the subclinical group than in the nonsubclinical group (50% versus 5.6%, Conclusions: Asymptomatic abnormalities detected using ICG lymphography are associated with an increased risk of subsequent lower limb lymphedema after gynecologic cancer surgery. However, not all subclinical cases progress, which supports the need for risk-based surveillance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.